Pregnancy decision-making in women with multiple sclerosis treated with natalizumab. iI maternal risks
- Portaccio, Emilio
- Moiola, Lucia
- Martinelli, Vittorio
- Annovazzi, Pietro
- Ghezzi, Angelo
- Zaffaroni, Mauro
- Lanzillo, Roberta
- Brescia Morra, Vincenzo
- Rinaldi, Francesca
- Gallo, Paolo
- Tortorella, Carla
- Paolicelli, Damiano
- Pozzilli, Carlo
- De Giglio, Laura
- Cavalla, Paola
- Cocco, Eleonora
- Marrosu, Maria Giovanna
- Solaro, Claudio
- Uccelli, Antonio
- Laroni, Alice
- Pastò, Luisa
- Giannini, Marta
- Trojano, Maria
- Comi, Giancarlo
- Amato, Maria Pia
Publication date
January 2018
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
To assess the risk of disease reactivation during pregnancy after natalizumab suspension in women with multiple sclerosis (MS)
Add to ORKG